Jonathan Halford to Drug Resistant Epilepsy
This is a "connection" page, showing publications Jonathan Halford has written about Drug Resistant Epilepsy.
Connection Strength
0.634
-
Safety and Efficacy of Natalizumab as Adjunctive Therapy for People With Drug-Resistant Epilepsy: A Phase 2 Study. Neurology. 2021 11 02; 97(18):e1757-e1767.
Score: 0.178
-
Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy. Neurology. 2020 09 01; 95(9):e1244-e1256.
Score: 0.165
-
Seizure freedom as an outcome in epilepsy treatment clinical trials. Acta Neurol Scand. 2020 Aug; 142(2):91-107.
Score: 0.163
-
The promise of subtraction ictal SPECT co-registered to MRI for improved seizure localization in pediatric epilepsies: Affecting factors and relationship to the surgical outcome. Epilepsy Res. 2017 01; 129:59-66.
Score: 0.128